Hematologic Neoplasms Clinical Trials
2 recruiting trials for Hematologic Neoplasms. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT05327023
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Background: People with blood cancers often receive blood or bone marrow transplants. But even with these treatments, the risk of relapse is high. Researchers want to see if...
Sponsor: National Cancer Institute (NCI)Enrolling: 4301 location
RECRUITINGPhase 3NCT07485855
Influenza Vaccination Strategy for Patients With Hematologic Malignancy
This randomized controlled trial evaluates and compares the immunogenicity of three different influenza vaccine formulations: high-dose trivalent (HD-IIV3), MF59-adjuvanted...
Sponsor: Asan Medical CenterEnrolling: 601 location